Annual Operating Expenses
$22.92 M
-$8.03 M-25.94%
December 31, 2023
Summary
- As of March 6, 2025, INKT annual total operating expenses is $22.92 million, with the most recent change of -$8.03 million (-25.94%) on December 31, 2023.
- During the last 3 years, INKT annual operating expenses has risen by +$12.12 million (+112.30%).
- INKT annual operating expenses is now -25.94% below its all-time high of $30.95 million, reached on December 31, 2022.
Performance
INKT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.88 M
-$1.19 M-38.63%
September 30, 2024
Summary
- As of March 6, 2025, INKT quarterly total operating expenses is $1.88 million, with the most recent change of -$1.19 million (-38.63%) on September 30, 2024.
- Over the past year, INKT quarterly operating expenses has stayed the same.
- INKT quarterly operating expenses is now -85.91% below its all-time high of $13.38 million, reached on September 30, 2021.
Performance
INKT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
INKT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.9% | 0.0% |
| 3 y3 years | +112.3% | 0.0% |
| 5 y5 years | -2.4% | 0.0% |
INKT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.9% | at low | -76.4% | at low |
| 5 y | 5-year | -25.9% | +112.3% | -85.9% | +23.6% |
| alltime | all time | -25.9% | +112.3% | -85.9% | +23.6% |
MiNK Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.88 M(-38.6%) |
| Jun 2024 | - | $3.07 M(-19.8%) |
| Mar 2024 | - | $3.83 M(-30.4%) |
| Dec 2023 | $22.92 M(-25.9%) | $5.50 M(+5.3%) |
| Sep 2023 | - | $5.22 M(-17.7%) |
| Jun 2023 | - | $6.34 M(+8.4%) |
| Mar 2023 | - | $5.85 M(-25.8%) |
| Dec 2022 | $30.95 M | $7.89 M(-1.2%) |
| Sep 2022 | - | $7.99 M(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.70 M(+4.4%) |
| Mar 2022 | - | $7.37 M(+15.9%) |
| Dec 2021 | $28.36 M(+162.7%) | $6.36 M(-52.4%) |
| Sep 2021 | - | $13.38 M(+138.3%) |
| Jun 2021 | - | $5.61 M(+86.6%) |
| Mar 2021 | - | $3.01 M(+97.3%) |
| Dec 2020 | $10.80 M(-54.0%) | $1.52 M(-74.3%) |
| Sep 2020 | - | $5.92 M |
| Dec 2019 | $23.48 M | - |
FAQ
- What is MiNK Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for MiNK Therapeutics?
- What is MiNK Therapeutics annual operating expenses year-on-year change?
- What is MiNK Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly operating expenses year-on-year change?
What is MiNK Therapeutics annual total operating expenses?
The current annual operating expenses of INKT is $22.92 M
What is the all time high annual operating expenses for MiNK Therapeutics?
MiNK Therapeutics all-time high annual total operating expenses is $30.95 M
What is MiNK Therapeutics annual operating expenses year-on-year change?
Over the past year, INKT annual total operating expenses has changed by -$8.03 M (-25.94%)
What is MiNK Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of INKT is $1.88 M
What is the all time high quarterly operating expenses for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly total operating expenses is $13.38 M
What is MiNK Therapeutics quarterly operating expenses year-on-year change?
Over the past year, INKT quarterly total operating expenses has changed by $0.00 (0.00%)